Biogen Inc.: Form 8-K, filed Jul 7, 2025
Filed with the SEC on Jul 7, 2025 and accepted by EDGAR at Jul 7, 2025, 16:10 ET.
Items reported
- Item 2.02 Results of operations
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000875045-25-000027. Last ingested by Listed: Nov 2, 2026, 20:22 ET. Listed shows no prices and gives no investment advice.